HELSINKI, Finland, April 2022. Viafet Genomics Laboratory, a leading laboratory in the field of human genetics in The United Arab Emirates has partnered with Euformatics to deploy highly automated genetic testing services in the Gulf region. The collaboration covers the full bioinformatics suite of Euformatics which are deployed in Viafet’s dedicated data centre in Dubai. Viafet plans to broaden its offering of clinical genetics services ranging from whole exome analysis to carrier screening and screening for hereditary cancer. The flexibility of OmnomicsNGS to support simultaneous single patient and multi-patient analysis and comparison was the key reason for Viafet to select Euformatics as their bioinformatics software provider to power their core production processes.
Dr. Samer Alfarawati, Laboratory Director at Viafet Genomics Laboratory comments on the partnership: “We initially looked for a software to perform carrier screening efficiently. After seeing the flexibility of OmnomicsNGS through the demos given by the Euformatics scientific team we realized that this tool can be used very broadly to many kinds of clinical NGS use cases. This feeling was confirmed through a trial period after which we committed to building our NGS pipelines together with Euformatics. Having quality control and NGS test validation as an integral part of the bioinformatics package gives us the confidence that the data we use is of high quality”.
“Viafet came into the discussions with a clear vision of what they wanted. We took their insight into our development and customized the patient reports so that the customer requirements were met already during the trial period. This helped us develop our reporting framework and is exactly what we expect from our partners. Our products become more competitive through these kinds of partnerships. We look forward to further optimizing our tools to improve productivity at Viafet’s clinical laboratory operations” adds Tommi Kaasalainen, CEO of Euformatics.
This partnership is the result of the growth we see in the Middle East in clinical NGS and the partnerships we already have in the Gulf region. Both constitutional genetics as well as cancer diagnostics using NGS are growing fast, and labs need better tools to analyse the patient samples.
About Viafet Genomics Laboratory :
Viafet has been providing high quality genetic testing and counselling services for over 10 years to local, regional, and international healthcare providers, and was the first genetic testing laboratory in the Middle East to be accredited by the College of American Pathologists (CAP) for Next-generation sequencing technology (NGS). With its long-standing vision of improving people’s lives through science, the Viafet team is dedicated to providing unparalleled genetic testing services through expertise and investment in the latest technologies. Viafet holds a unique and strong database of rare-disease genomics, uniquely positioning Viafet as a key leader in diagnostic genetics in the region. Viafet has also taken great strides in providing highly advanced reproductive genetic testing options, to help inspire the growth of healthy future generations that are devoid of genetic disorders.
More information is available at their website: www.viafet.ae
About Euformatics:
Euformatics is a Finnish company that provides high-standard software for genomic data interpretation. Since 2010, Euformatics has been helping medical doctors and molecular genetics laboratories provide better precision medicine for cancer, common or rare disease diagnostics. At present, our core solution is the omnomics suite which includes omnomicsNGS; a CE-IVD clinical analysis and reporting of patient NGS data, omnomicsQ; for NGS data quality management, and omnomicsV; for NGS assay pipeline validation.
For more information, please visit our website www.euformatics.com
Press relations:
Tommi Kaasalainen
Euformatics
tommi.kaasalainen@euformatics.com
